Bank Of Montreal »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Bank Of Montreal

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Bank Of Montreal from 13F filings

Historical chart of Bank Of Montreal investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Bank Of Montreal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Bank Of Montreal

Quarter filed Position value Share count Share price at filing
2023-12-31 $28M 27M 1.02
2023-09-30 $33M 29M 1.13

More positions owned by Bank Of Montreal

Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Tesla Motors (TSLA)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bk Nova Cad (BNS)
Meta Platforms Cl A (META)
Cibc Cad (CM)
Bank Of Montreal Cadcom (BMO)
Walt Disney Company (DIS)

View all positions for Bank Of Montreal

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Capstone Investment Advisors
Weiss Asset Management LP[1
CNH Partners

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1